The U.S. Supreme Court issued a temporary order restoring broad access to the abortion pill Mifepristone, allowing distribution through pharmacies and by mail without requiring an in-person doctor visit. The decision, signed by Justice Samuel Alito, blocks a lower court ruling that had halted mail delivery of the drug nationwide.
The case follows a challenge by Louisiana Attorney General Elizabeth Murrell, who argued that the Food and Drug Administration’s removal of in-person requirements allowed abortion pills to bypass state pro-life laws. Murrell stated, “After Dobbs, the Biden FDA promptly announced that it would remove the in-person dispensing requirements for abortion pills, thereby authorizing Mifepristone to be shipped nationwide by mail.”
Medical concerns were also raised during Senate testimony. Obstetrician-gynecologist Dr. Monique Wubbenhorst warned, “The different risks that are associated are bleeding, infection, hemorrhage, need for transfusion, and perforation.”
The Supreme Court’s action pauses the lower court decision while the legal challenge continues. The case remains under review, with further proceedings expected to determine the long-term legality of mail-order abortion drugs in the United States.
